The regulatory body issued the CRL stating that it cannot approve the sNDA in its current form. Shares of Vanda have plunged 36.9% in the past year compared with the industry’s decline of 3.7%.

The acknowledgment of the SNDA by the FDA is a procedural step, indicating that the submission has been officially received and will undergo a review process. However, it does not imply any form ...